Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Net Income (2016 - 2025)

Theravance Biopharma has reported Net Income over the past 13 years, most recently at -$58.9 million for Q4 2025.

  • Quarterly Net Income fell 235.74% to -$58.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.0 million through Dec 2025, up 76.0% year-over-year, with the annual reading at -$14.0 million for FY2025, 76.02% up from the prior year.
  • Net Income was -$58.9 million for Q4 2025 at Theravance Biopharma, down from $3.6 million in the prior quarter.
  • Over five years, Net Income peaked at $927.1 million in Q3 2022 and troughed at -$58.9 million in Q4 2025.
  • The 5-year median for Net Income is -$2.4 million (2023), against an average of $45.1 million.
  • Year-over-year, Net Income skyrocketed 4400.0% in 2022 and then plummeted 318.54% in 2023.
  • A 5-year view of Net Income shows it stood at $25.8 million in 2021, then crashed by 84.9% to $3.9 million in 2022, then tumbled by 318.54% to -$8.5 million in 2023, then crashed by 106.12% to -$17.5 million in 2024, then plummeted by 235.74% to -$58.9 million in 2025.
  • Per Business Quant, the three most recent readings for TBPH's Net Income are -$58.9 million (Q4 2025), $3.6 million (Q3 2025), and $54.8 million (Q2 2025).